What is the appropriate diagnosis and treatment for a 36-year-old male with a 2-week history of itching and penile discharge, positive for Mycoplasma hominis and Ureaplasma parvum, and having a urine culture positive for leukocyte esterase and WBC?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Nongonococcal Urethritis (NGU)

This patient has documented nongonococcal urethritis caused by Ureaplasma parvum and/or Mycoplasma hominis, and should be treated immediately with doxycycline 100 mg orally twice daily for 7 days. 1, 2, 3

Diagnostic Confirmation

This patient meets CDC criteria for confirmed urethritis based on:

  • Positive leukocyte esterase test on first-void urine 4, 2
  • Presence of WBCs in urine (>10 WBCs per high-power field) 4, 2
  • Clinical symptoms of penile discharge and itching consistent with urethritis 2

The diagnosis is nongonococcal urethritis (NGU) because gonorrhea and chlamydia testing should be performed first, and if negative (as implied by the focus on Mycoplasma/Ureaplasma), these organisms become the likely pathogens. 4

Critical Context About These Organisms

Do not be misled by the positive Ureaplasma parvum and Mycoplasma hominis results alone—these organisms frequently colonize healthy individuals without causing disease. 1, 5

However, this patient has documented urethritis symptoms and objective signs of inflammation, which changes the clinical picture entirely:

  • The CDC recommends treating Ureaplasma only when patients have documented urethritis symptoms (mucopurulent discharge, dysuria, urethral pruritis) or objective signs (>5 WBCs per oil immersion field on Gram stain, positive leukocyte esterase, or >10 WBCs per high-power field on first-void urine). 1
  • The European STI Guidelines Editorial Board confirms that routine testing for M. hominis and Ureaplasma species is not recommended in asymptomatic individuals, but this patient is symptomatic. 5

Treatment Protocol

First-line treatment: Doxycycline 100 mg orally twice daily for 7 days 4, 1, 2, 3

This regimen is supported by:

  • FDA-approved dosing for nongonococcal urethritis caused by C. trachomatis or U. urealyticum 3
  • CDC guidelines for NGU management 4, 2
  • Research showing 94.6% sensitivity of U. urealyticum to doxycycline and 83.3% sensitivity of M. hominis to doxycycline 6

Alternative regimen (if doxycycline contraindicated):

  • Azithromycin 1 g orally as single dose 4, 1, 7
  • Erythromycin base 500 mg orally four times daily for 7 days 4, 1, 2

Partner Management

All sexual partners within the preceding 60 days require evaluation and empiric treatment with the same regimen. 1, 2

  • Partners with last sexual contact within 30 days of symptom onset should be prioritized for treatment 1, 2
  • Both patient and partners must abstain from sexual intercourse for 7 days after completing the 7-day regimen 1

Critical Pitfalls to Avoid

Do not treat based on positive Ureaplasma/Mycoplasma testing alone without documented urethritis—this is the most common error. 1, 5

  • Asymptomatic carriage of these organisms occurs in 40-80% of sexually active individuals 5
  • The European STI Guidelines Editorial Board warns that routine testing and treatment may result in antimicrobial resistance selection and substantial economic cost 5

Do not assume this is a urinary tract infection (UTI) requiring different antibiotics:

  • The CDC advises against treating for UTI based on pyuria alone in patients with confirmed or suspected STI 8
  • Leukocyte esterase has 93% sensitivity but only 72% specificity for UTI, and in this context of penile discharge and itching, urethritis is the correct diagnosis 8

Do not confuse U. parvum with U. urealyticum regarding fertility implications:

  • Only U. urealyticum (not U. parvum) is associated with male infertility based on meta-analysis evidence 1
  • However, this distinction does not change acute treatment, as both respond to doxycycline 1, 6

Follow-Up Strategy

Patients should return for evaluation only if symptoms persist or recur after completing therapy. 4, 2

  • If no improvement is seen within 3 days of starting treatment, re-evaluate the diagnosis 2
  • Consider testing for Mycoplasma genitalium if symptoms persist, as this organism causes 15-25% of NGU cases and has rising resistance to first-line agents 4
  • If symptoms continue beyond 3 months despite appropriate treatment, consider chronic prostatitis/chronic pelvic pain syndrome and refer to urology 2

References

Guideline

Ureaplasma Infection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach and Management of Urethritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Sexually Transmitted Infections and Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment for a patient with detected Ureaplasma parvum and Ureaplasma urealyticum DNA, and negative results for Mycoplasma hominis, Mycoplasma genitalium, and other relevant tests?
Are Mycoplasma hominis and Ureaplasma (U.) parvum considered sexually transmitted diseases (STDs)?
What is the recommended treatment for a non-sexually active patient with a positive Ureaplasma test result?
How is Bacterial Vaginosis (BV) tested in males?
Are mycoplasma and ureaplasma treated the same?
What is considered a healthy bowel movement pattern and how can I manage constipation or diarrhea?
Can a patient with low testosterone levels take Clomid (clomiphene citrate) to increase their testosterone levels?
What is the risk of stroke in an adult patient with potential vascular risk factors such as hypertension, diabetes, or hyperlipidemia, within one week after a Transient Ischemic Attack (TIA)?
What are suitable blood pressure medications for a patient with impaired renal function, on prednisone (corticosteroid) and upadacitinib (Janus kinase inhibitor), considering potential interactions and kidney function monitoring?
What are the symptoms of low pregnenolone levels in adults, particularly those over 40 years old?
What can be added to the medication regimen of an elderly female patient with major depressive disorder, recurrent and severe, without psychotic features, Alzheimer's disease, and dementia, who is currently taking aripiprazole (Abilify) 10 mg at bedtime, mirtazapine (Remeron) 30 mg at bedtime, and amitriptyline (Elavil) 10 mg twice a day, and is experiencing exit seeking and anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.